Home » Healthcare » Optical Preclinical Imaging Market

Optical Preclinical Imaging Market By Modality (Bioluminescence/Fluorescence Imaging Systems, Standalone Fluorescence Imaging Systems, Optical + X-Ray/Optical + CT) By Reagent (Bioluminescent Imaging Reagents, Fluorescent Imaging Reagents) By Application (Research & Development, Drug Discovery) – Growth, Future Prospects, And Competitive Analysis, 2016 -2028

Price: $4999

Published: | Report ID: 8045 | Report Format : PDF

About this report

The global Optical Preclinical Imaging Market report explores the critical analysis of the Optical Preclinical Imaging industry using key parameters. The report consists of investment strategies, the need for investments in the Optical Preclinical Imaging industry, and the multiple benefits for the investors. Importantly, this report sets out major changes in the global technical regulations for the Optical Preclinical Imaging industry and how economic and non-economic barriers are helping the Optical Preclinical Imaging market grow. Moreover, the report analyzes the global, regional, and country-level historic and forecasted market size. The report also provides a comprehensive analysis of key investment propositions, demand and supply gap, competitors positioning, STAR analysis, SRC analysis, and Tornado analysis. Key technological developments and other analyses such as porter’s five forces analysis, PESTEL analysis, value chain analysis, etc.

Optical Preclinical Imaging Market

 

Key Highlights of the report

How are the major segments performing in the Optical Preclinical Imaging Market?

In 2021, the bioluminescence/fluorescence imaging systems segment will be the leading segment by modality due to the rapid commercialization of these systems and their technologically advanced integration.

In 2021, the research institutes segment was the major segment by end-user. In-vivo imaging systems are being adopted by more clinical research institutes and pharmaceutical companies in preclinical research, which is further anticipated to fuel the growth of this market. Moreover, alternative approaches for clinical research, including in-vitro testing, micro-dosing, computer-based models, virtual drug testing, and creating computerized databases for testing, are being adopted more and more frequently by research institutes.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Which region dominated the Optical Preclinical Imaging Market?

The optical preclinical imaging market was dominated by North America in 2021, with a revenue share of about 29%. The presence of qualified specialists, a sizable number of preclinical projects, and greater acceptance rates of technologically advanced equipment in the region are some key market factors in North America. Additionally, regional clinical research and development programs are being encouraged by government initiatives. One such government program promoting R&D efforts in the nation is the Canadian R&D tax credit scheme. The market is benefiting from government support through money and tax breaks.

What is the competitive environment of the Optical Preclinical Imaging Market?

The optical preclinical imaging market is quite competitive and fragmented. Market participants actively put strategic initiatives into action, such as portfolio diversification, product enhancements, geographical expansions, and mergers and acquisitions. These firms also frequently work with academic institutions, universities, and other end users to influence preclinical research in the market. For instance, in October 2020, prestigious institutions placed orders of up to $10 million with MR Solutions for their preclinical equipment. The most popular products among market participants included 9.4T and 7T cryogen-free DRY magnets, PET/CTs, and PET/MRs.

Executive Summary

What are the technological developments being developed in the Optical Preclinical Imaging Market?

Research in important fields like oncology, cardiology, infection, and neurology will continue to expand as a result of the combination of high-resolution modalities like micro-CT or micro-MRI with highly sensitive methods that provide functional information like micro-PET or micro-SPECT, helping to not only understand the underlying mechanisms of disease but also providing effective and special tools for assessing novel chemical entities and candidate drugs. Because of their increased benefits, pharmaceutical corporations, contract research organizations, and academic institutions rapidly use small-animal imaging techniques.

Which are the key investments by the players in the Optical Preclinical Imaging Market?

Key players make various investments throughout the market through acquisitions and new product launches to expand their business revenue mix. For instance, the seventh generation of preclinical imagers was introduced by MILABS during the 2021 World Molecular Imaging Conference in October. MILabs is elevating the value of its ecosystem of preclinical goods under the new ownership of the Rigaku Group (Tokyo, Japan). MOLECUBES, NV, a dynamic innovator in benchtop preclinical nuclear molecular imaging (NMI) systems, was acquired by The Bruker Corporation in November 2021. The position of Bruker as a premier NMI solutions provider for preclinical and translational imaging research is strengthened by this purchase.

Some of the major players in the market are Bruker Corporation, MR Solutions, PerkinElmer, Inc., TriFoil Imaging, FUJIFILM Holdings America Corporation, Mediso Ltd., Miltenyi Biotec, Vieworks Co., Ltd., UVP, and MILabs B.V.

What are the Major Driving Factors for the Optical Preclinical Imaging Market?

The market is expanding primarily due to increased investments and financing for R&D, as well as the rapid pace of technological improvements that have led to the creation of hybrid imaging systems. Preclinical research is changing how modern medicine is practiced and addresses health issues. Preclinical imaging methods fully adhere to 3R (Replacement, Reduction, and Refinement) policies by reducing biological variability, acquiring a remarkable amount of distinctive information in various forms, and drastically reducing the number of animals needed for a given study. As there are more Clinical Research Organizations (CROs) and pharmaceutical companies, in-vivo imaging systems are being used more frequently in preclinical research, which is anticipated to boost the expansion of this market.

What are the Major Risks for the Optical Preclinical Imaging Market?

The main obstacles to the market’s expansion are the limitations on animal testing imposed by laws enforced by groups that defend animal rights. Alternative techniques are quickly gaining acceptance, including in-vitro tests, microdosing, computer-based models, virtual drug testing, and the development of computerized databases for testing. High installation and operating costs are another significant industry constraint.

Which is the key modality in the Optical Preclinical Imaging Market?

The bioluminescence/fluorescence imaging systems dominated the Optical Preclinical Imaging market in 2021. Molecular events and biological processes can be studied in vivo without intervention using the optical imaging technique known as bioluminescence. This imaging technique is non-invasive and permits real-time biological process analysis. Thanks to this approach, researchers have analyzed disease development, protein-protein interactions, therapeutic success, and many other topics. Comparing bioluminescence to traditional fluorescence readouts, there are several distinctive benefits. The main benefit of using bioluminescent signals is that they can be used for long-term imaging applications with no risk of phototoxicity or artifact since they can be recognized over very little to no background noise. High sensitivity, high specificity, no phototoxicity (damage caused by high and low wavelength light), and non-invasiveness are all benefits of bioluminescence imaging. High signal-to-noise ratio (low background), simultaneous imaging of multiple organisms (instrument dependent), high sensitivity, and high specificity are other benefits.

How is the Optical Preclinical Imaging Market performing in regions?

North America dominated the optical preclinical imaging market with a revenue share of almost 29% in 2021. Some of the important market aspects in North America are the availability of qualified specialists, the sizeable number of preclinical projects, and higher adoption rates of technologically advanced equipment in the region. Government initiatives are also supporting regional clinical research and development programs. The Canadian R&D tax credit program is one of the government initiatives supporting national R&D activities. Government assistance in the form of funds and tax breaks benefits the market. Due to its developed infrastructure and significant governmental and private firms, the United States is also recognized as the market leader. The preclinical imaging market is expanding more quickly in the United States thanks to increased funding for research and development and well-established research infrastructure. Additionally, the rising usage of in-vivo imaging systems in Preclinical research due to the rise in clinical research organizations (CROs) and pharmaceutical corporations is further fueling the growth of this market.

The market is expanding profitably throughout the Asia Pacific. Preclinical research studies are attracted to the region due to inexpensive research costs, lax regulatory requirements, and increased government financing for the growth of the research and development sector in different countries. As a result, growing nations like China and India are experiencing rapid growth in the Clinical Research Outsourcing (CRO) sector.

What is the regulatory landscape for the Optical Preclinical Imaging Market?

The market for optical preclinical imaging is anticipated to have difficulties due to the strict regulatory environment governing preclinical research. The technical and procedural rules are developed about autonomous systems and the demand for proof based on clinical trials. Additionally, governments have implemented strict restrictions on animal testing.

What is the Market Size of Optical Preclinical Imaging regarding value?

The global Optical Preclinical Imaging Market is anticipated to grow at a substantial CAGR of 5.0% in the upcoming years. The global Optical Preclinical Imaging industry was estimated to be worth USD 519.4 million in 2021 and was expected to be worth USD 696.1 million by 2028.

What are the major players planning for the future of the Optical Preclinical Imaging Market?

Businesses are introducing new items to diversify their product line. For instance, according to Bruker, the market-leading Ultima family of multiphoton microscopes for deep tissue fluorescence imaging will introduce the Ultima Investigator Plus in March 2022. With an enlarged close-coupled collecting path, an expanded field of view, and optimized optics for two- and three-photon imaging, Investigator Plus improves scientists’ ability to image deeply and see more inside challenging specimens. Additionally, businesses are developing new items to diversify their product offering. For instance, Bruker announced that the Ultima Investigator Plus, the most recent flexible platform addition to the leading-edge Ultima line of multiphoton microscopes for deep tissue fluorescence imaging, would be released in March 2022.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Segmentation of Global Optical Preclinical Imaging Market-

Global Optical Preclinical Imaging Market – By Modality

  • Bioluminescence/Fluorescence Imaging Systems
  • Standalone Fluorescence Imaging Systems
  • Optical + X-Ray/Optical + CT

 Global Proximal Humerous Implants Market – By Reagent

  • Bioluminescent Imaging Reagents
  • Fluorescent Imaging Reagents

Global Optical Preclinical Imaging Market – By Application

  • Research & Development
  • Drug Discovery

Global Optical Preclinical Imaging Market – By End-user

  • Pharmaceutical Companies
  • Biotech Companies
  • Research Institutes

Global Optical Preclinical Imaging Market – By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation

2. Executive Summary
2.1. Market Snapshot: Global Optical Preclinical Imaging Market
2.2. Global Optical Preclinical Imaging Market, By Modality
2.3. Global Optical Preclinical Imaging Market, By Reagent
2.4. Global Optical Preclinical Imaging Market, By Application
2.5. Global Optical Preclinical Imaging Market, By End-User
2.6. Global Optical Preclinical Imaging Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Optical Preclinical Imaging Market Value, 2016-2028, (US$ Bn)
3.2. Market Dynamics
3.2.1. Key Growth Trends
3.2.2. Market Drivers
3.2.3. Market Restraints
3.2.4. Market Opportunities
3.2.5. Major Industry Challenges
3.3. Attractive Investment Proposition,2021
3.3.1. Modality
3.3.2. Reagent
3.3.3. Application
3.3.4. End-User
3.3.5. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Value Chain Analysis
4.4. Technology Analysis
4.5. Marketing Strategy Analysis
4.5.1. Direct Marketing
4.5.2. Indirect Marketing
4.5.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2021
5.1. Company market share of key players, 2021
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. COVID 19 Impact Analysis
6.1. Global Optical Preclinical Imaging Market Pre Vs Post COVID 19, 2019 – 2028
6.2. Impact on Import & Export
6.3. Impact on Demand & Supply

7. Global Optical Preclinical Imaging Market
7.1. Global Optical Preclinical Imaging Market, By Modality, 2016-2028(US$ Bn)
7.1.1. Overview
7.1.2. Global Optical Preclinical Imaging Market, By Modality, 2021 vs 2028 (in%)
7.1.3. Global Optical Preclinical Imaging Market, By Bioluminescence/Fluorescence Imaging Systems, 2016-2028 (US$ Bn)
7.1.4. Global Optical Preclinical Imaging Market, By Standalone Fluorescence Imaging Systems, 2016-2028 (US$ Bn)
7.1.5. Global Optical Preclinical Imaging Market, By Optical + X-Ray/Optical + CT, 2016-2028 (US$ Bn)
7.2. Global Optical Preclinical Imaging Market, By Reagent, 2016-2028(US$ Bn)
7.2.1. Overview
7.2.2. Global Optical Preclinical Imaging Market, By Reagent, 2021 vs 2028 (in%)
7.2.3. Global Optical Preclinical Imaging Market, By Bioluminescent Imaging Reagents, 2016-2028 (US$ Bn)
7.2.4. Global Optical Preclinical Imaging Market, By Fluorescent Imaging Reagents, 2016-2028 (US$ Bn)
7.3. Global Optical Preclinical Imaging Market, By Application, 2016-2028(US$ Bn)
7.3.1. Overview
7.3.2. Global Optical Preclinical Imaging Market, By Application, 2021 vs 2028 (in%)
7.3.3. Global Optical Preclinical Imaging Market, By Research & Development, 2016-2028 (US$ Bn)
7.3.4. Global Optical Preclinical Imaging Market, By Drug Discovery, 2016-2028 (US$ Bn)
7.4. Global Optical Preclinical Imaging Market, By End-User, 2016-2028(US$ Bn)
7.4.1. Overview
7.4.2. Global Optical Preclinical Imaging Market, By End-User, 2021 vs 2028 (in%)
7.4.3. Global Optical Preclinical Imaging Market, By Pharmaceutical Companies, 2016-2028 (US$ Bn)
7.4.4. Global Optical Preclinical Imaging Market, By Biotech Companies, 2016-2028 (US$ Bn)
7.4.5. Global Optical Preclinical Imaging Market, By Research Institutes, 2016-2028 (US$ Bn)

8. North America Optical Preclinical Imaging Market Analysis
8.1. North America Optical Preclinical Imaging Market, By Modality, 2016-2028(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Optical Preclinical Imaging Market, By Reagent, 2016-2028(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Optical Preclinical Imaging Market, By Application, 2016-2028(US$ Bn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America Optical Preclinical Imaging Market, By End-User, 2016-2028(US$ Bn)
8.4.1. Overview
8.4.2. SRC Analysis
8.5. North America Optical Preclinical Imaging Market, by Country, 2016-2028 (US$ Bn)
8.5.1. U.S.
8.5.1.1. U.S. Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.5.1.2. U.S. Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
8.5.1.3. U.S. Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
8.5.1.4. U.S. Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
8.5.1.5. U.S. Optical Preclinical Imaging, By End User, 2016-2028 (US$ Bn)
8.5.2. Canada
8.5.2.1. Canada Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.5.2.2. Canada Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
8.5.2.3. Canada Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
8.5.2.4. Canada Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
8.5.2.5. Canada Optical Preclinical Imaging, By End User, 2016-2028 (US$ Bn)

9. Europe Optical Preclinical Imaging Market Analysis
9.1. Europe Optical Preclinical Imaging Market, By Modality, 2016-2028(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Optical Preclinical Imaging Market, By Reagent, 2016-2028(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Optical Preclinical Imaging Market, By Application, 2016-2028(US$ Bn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe Optical Preclinical Imaging Market, By End-User, 2016-2028(US$ Bn)
9.4.1. Overview
9.4.2. SRC Analysis
9.5. Europe Optical Preclinical Imaging Market, by Country, 2016-2028 (US$ Bn)
9.5.1. Germany
9.5.1.1. Germany Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.5.1.2. Germany Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
9.5.1.3. Germany Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
9.5.1.4. Germany Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
9.5.1.5. Germany Optical Preclinical Imaging, By End User, 2016-2028 (US$ Bn)
9.5.2. France
9.5.2.1. France Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.5.2.2. France Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
9.5.2.3. France Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
9.5.2.4. France Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
9.5.2.5. France Optical Preclinical Imaging, By End-User, 2016-2028 (US$ Bn)
9.5.3. UK
9.5.3.1. UK Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.5.3.2. UK Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
9.5.3.3. UK Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
9.5.3.4. UK Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
9.5.3.5. UK Optical Preclinical Imaging, By End User, 2016-2028 (US$ Bn)
9.5.4. Italy
9.5.4.1. Italy Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.5.4.2. Italy Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
9.5.4.3. Italy Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
9.5.4.4. Italy Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
9.5.4.5. Italy Optical Preclinical Imaging, By End User, 2016-2028 (US$ Bn)
9.5.5. Spain
9.5.5.1. Spain Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.5.5.2. Spain Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
9.5.5.3. Spain Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
9.5.5.4. Spain Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
9.5.5.5. Spain Optical Preclinical Imaging, By End User, 2016-2028 (US$ Bn)
9.5.6. Rest of Europe
9.5.6.1. Rest of Europe Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.5.6.2. Rest of Europe Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
9.5.6.3. Rest of Europe Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
9.5.6.4. Rest of Europe Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
9.5.6.5. Rest of Europe Optical Preclinical Imaging, By End User, 2016-2028 (US$ Bn)

10. Asia Pacific Optical Preclinical Imaging Market Analysis
10.1. Asia Pacific Optical Preclinical Imaging Market, By Modality, 2016-2028(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Optical Preclinical Imaging Market, By Reagent, 2016-2028(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Optical Preclinical Imaging Market, By Application, 2016-2028(US$ Bn)
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific Optical Preclinical Imaging Market, by End User, 2016-2028(US$ Bn)
10.4.1. Overview
10.4.2. SRC Analysis
10.5. Asia Pacific Optical Preclinical Imaging Market, by Country, 2016-2028 (US$ Bn)
10.5.1. China
10.5.1.1. China Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.5.1.2. China Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
10.5.1.3. China Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
10.5.1.4. China Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
10.5.1.5. China Optical Preclinical Imaging, By End User, 2016-2028 (US$ Bn)
10.5.2. Japan
10.5.2.1. Japan Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.5.2.2. Japan Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
10.5.2.3. Japan Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
10.5.2.4. Japan Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
10.5.2.5. Japan Optical Preclinical Imaging, By End User, 2016-2028 (US$ Bn)
10.5.3. India
10.5.3.1. India Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.5.3.2. India Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
10.5.3.3. India Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
10.5.3.4. India Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
10.5.3.5. India Optical Preclinical Imaging, By End User, 2016-2028 (US$ Bn)
10.5.4. South Korea
10.5.4.1. South Korea Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.5.4.2. South Korea Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
10.5.4.3. South Korea Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
10.5.4.4. South Korea Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
10.5.4.5. South Korea Optical Preclinical Imaging, By End User, 2016-2028 (US$ Bn)
10.5.5. South-East Asia
10.5.5.1. South-East Asia Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.5.5.2. South-East Asia Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
10.5.5.3. South-East Asia Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
10.5.5.4. South-East Asia Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
10.5.5.5. South-East Asia Optical Preclinical Imaging, By End User, 2016-2028 (US$ Bn)
10.5.6. Rest of Asia Pacific
10.5.6.1. Rest of Asia Pacific Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.5.6.2. Rest of Asia Pacific Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
10.5.6.3. Rest of Asia Pacific Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
10.5.6.4. Rest of Asia Pacific Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
10.5.6.5. Rest of Asia Pacific Optical Preclinical Imaging, By End-User, 2016-2028 (US$ Bn)

11. Latin America Optical Preclinical Imaging Market Analysis
11.1. Latin America Optical Preclinical Imaging Market, By Modality, 2016-2028(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Optical Preclinical Imaging Market, By Reagent, 2016-2028(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Optical Preclinical Imaging Market, By Application, 2016-2028(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America Optical Preclinical Imaging Market, By End-User, 2016-2028(US$ Bn)
11.4.1. Overview
11.4.2. SRC Analysis
11.5. Latin America Optical Preclinical Imaging Market, by Country, 2016-2028 (US$ Bn)
11.5.1. Brazil
11.5.1.1. Brazil Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.5.1.2. Brazil Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
11.5.1.3. Brazil Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
11.5.1.4. Brazil Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
11.5.1.5. Brazil Optical Preclinical Imaging, By End User, 2016-2028 (US$ Bn)
11.5.2. Mexico
11.5.2.1. Mexico Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.5.2.2. Mexico Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
11.5.2.3. Mexico Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
11.5.2.4. Mexico Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
11.5.2.5. Mexico Optical Preclinical Imaging, By End User, 2016-2028 (US$ Bn)
11.5.3. Rest of Latin America
11.5.3.1. Rest of Latin America Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.5.3.2. Rest of Latin America Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
11.5.3.3. Rest of Latin America Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
11.5.3.4. Rest of Latin America Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
11.5.3.5. Rest of Latin America Optical Preclinical Imaging, By End User, 2016-2028 (US$ Bn)

12. Middle East and Africa Optical Preclinical Imaging Market Analysis
12.1. Middle East and Africa Optical Preclinical Imaging Market, By Modality, 2016-2028(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Optical Preclinical Imaging Market, By Reagent, 2016-2028(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Optical Preclinical Imaging Market, By Application, 2016-2028(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa Optical Preclinical Imaging Market, By End-User, 2016-2028(US$ Bn)
12.4.1. Overview
12.4.2. SRC Analysis
12.5. Middle East and Africa Optical Preclinical Imaging Market, by Country, 2016-2028 (US$ Bn)
12.5.1. GCC Countries
12.5.1.1. GCC Countries il Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.5.1.2. GCC Countries Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
12.5.1.3. GCC Countries Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
12.5.1.4. GCC Countries Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
12.5.1.5. GCC Countries Optical Preclinical Imaging, By End User, 2016-2028 (US$ Bn)
12.5.2. South Africa
12.5.2.1. South Africa Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.5.2.2. South Africa Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
12.5.2.3. South Africa Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
12.5.2.4. South Africa Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
12.5.2.5. South Africa Optical Preclinical Imaging, By End User, 2016-2028 (US$ Bn)
12.5.3. Rest of Middle East and Africa
12.5.3.1. Rest of Middle East and Africa Optical Preclinical Imaging Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.5.3.2. Rest of Middle East and Africa Optical Preclinical Imaging, By Modality, 2016-2028 (US$ Bn)
12.5.3.3. Rest of Middle East and Africa Optical Preclinical Imaging, By Reagent, 2016-2028 (US$ Bn)
12.5.3.4. Rest of Middle East and Africa Optical Preclinical Imaging, By Application, 2016-2028 (US$ Bn)
12.5.3.5. Rest of Middle East and Africa Optical Preclinical Imaging, By End User, 2016-2028 (US$ Bn)

13. Company Profiles
13.1. Bruker Corporation
13.1.1. Company Overview
13.1.2. Products/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2021)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. MR Solutions
13.3. PerkinElmer, Inc.
13.4. TriFoil Imaging
13.5. FUJIFILM Holdings America Corporation
13.6. Mediso Ltd.
13.7. Miltenyi Biotec
13.8. Vieworks Co., Ltd.
13.9. UVP
13.10. MILabs B.V.
13.11. Others

 

List of Figures

FIG. 1 Global Optical Preclinical Imaging Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Optical Preclinical Imaging Market Segmentation
FIG. 4 Global Optical Preclinical Imaging Market, By Modality, 2021 (US$ Bn)
FIG. 5 Global Optical Preclinical Imaging Market, By Reagent, 2021 (US$ Bn)
FIG. 6 Global Optical Preclinical Imaging Market, By Application Type, 2021 (US$ Bn)
FIG. 7 Global Optical Preclinical Imaging Market, By End-User, 2021 (US$ Bn)
FIG. 8 Global Optical Preclinical Imaging Market, by Geography, 2021 (US$ Bn)
FIG. 9 Attractive Investment Proposition, By Modality, 2021
FIG. 10 Attractive Investment Proposition, By Reagent, 2021
FIG. 11 Attractive Investment Proposition, By Application Type, 2021
FIG. 12 Attractive Investment Proposition, By End-User, 2021
FIG. 13 Attractive Investment Proposition, by Geography, 2021
FIG. 14 Global Market Share Analysis of Key Optical Preclinical Imaging Market Manufacturers, 2021
FIG. 15 Global Market Positioning of Key Optical Preclinical Imaging Market Manufacturers, 2021
FIG. 16 Global Optical Preclinical Imaging Market Value Contribution, By Modality, 2021 & 2028 (Value %)
FIG. 17 Global Optical Preclinical Imaging Market, by Bioluminescence/Fluorescence Imaging Systems, Value, 2016-2028 (US$ Bn)
FIG. 18 Global Optical Preclinical Imaging Market, by Standalone Fluorescence Imaging Systems, Value, 2016-2028 (US$ Bn)
FIG. 19 Global Optical Preclinical Imaging Market, By Optical + X-Ray/Optical + CT, Value, 2016-2028 (US$ Bn)
FIG. 20 Global Optical Preclinical Imaging Market Value Contribution, By Reagent, 2021 & 2028 (Value %)
FIG. 21 Global Optical Preclinical Imaging Market, By Bioluminescent Imaging Reagents, Value, 2016-2028 (US$ Bn)
FIG. 22 Global Optical Preclinical Imaging Market, By Fluorescent Imaging Reagents, Value, 2016-2028 (US$ Bn)
FIG. 23 Global Optical Preclinical Imaging Market Value Contribution, By Application, 2021 & 2028 (Value %)
FIG. 24 Global Optical Preclinical Imaging Market, By Research & Development, Value, 2016-2028 (US$ Bn)
FIG. 25 Global Optical Preclinical Imaging Market, By Drug Discovery, Value, 2016-2028 (US$ Bn)
FIG. 26 Global Optical Preclinical Imaging Market Value Contribution, By End-User, 2021 & 2028 (Value %)
FIG. 27 Global Optical Preclinical Imaging Market, By Pharmaceutical Companies, Value, 2016-2028 (US$ Bn)
FIG. 28 Global Optical Preclinical Imaging Market, By Biotech Companies, Value, 2016-2028 (US$ Bn)
FIG. 29 Global Optical Preclinical Imaging Market, By Research Institutes, Value, 2016-2028 (US$ Bn)
FIG. 30 U.S. Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 31 Canada Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 32 Germany Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 33 France Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 34 U.K. Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 35 Italy Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 36 Spain Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 37 Rest of Europe Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 38 China Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 39 Japan Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 40 India Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 41 South Korea Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 42 Southeast Asia Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 43 Rest of Asia Pacific Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 44 Latin America Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 45 Brazil Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 46 Mexico Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 47 Rest of Latin America Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 48 Middle East & Africa Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 49 GCC Countries Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 50 South Africa Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)
FIG. 51 Rest of Middle East and Africa Optical Preclinical Imaging Market, 2016-2028 (US$ Bn)

List of Tables

TABLE 1 Market Snapshot: Global Optical Preclinical Imaging Market
TABLE 2 Global Optical Preclinical Imaging Market, by Competitive Benchmarking, 2021
TABLE 3 Global Optical Preclinical Imaging Market, by Geographical Presence Analysis, 2021
TABLE 4 Global Optical Preclinical Imaging Market, by Key Strategies Analysis, 2021
TABLE 5 Global Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 6 Global Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 7 Global Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 8 Global Optical Preclinical Imaging Market, By End-User, 2016-2028 (US$ Bn)
TABLE 9 Global Optical Preclinical Imaging Market, by Geography, 2016-2028 (US$ Bn)
TABLE 10 North America Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 11 North America Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 12 North America Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 13 North America Optical Preclinical Imaging Market, By End-User, 2016-2028 (US$ Bn)
TABLE 14 North America Optical Preclinical Imaging Market, by Country, 2016-2028 (US$ Bn)
TABLE 15 US Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 16 US Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 17 US Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 18 US Optical Preclinical Imaging Market, By End-User, 2016-2028 (US$ Bn)
TABLE 19 Canada Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 20 Canada Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 21 Canada Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 22 Canada Optical Preclinical Imaging Market, By End-User, 2016-2028 (US$ Bn)
TABLE 23 Europe Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 24 Europe Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 25 Europe Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 26 Europe Optical Preclinical Imaging Market, By End-User, 2016-2028 (US$ Bn)
TABLE 27 Europe Optical Preclinical Imaging Market, by Country, 2016-2028 (US$ Bn)
TABLE 28 Germany Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 29 Germany Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 30 Germany Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 31 Germany Optical Preclinical Imaging Market, by End User, 2016-2028 (US$ Bn)
TABLE 32 France Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 33 France Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 34 France Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 35 France Optical Preclinical Imaging Market, by End User, 2016-2028 (US$ Bn)
TABLE 36 UK Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 37 UK Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 38 UK Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 39 UK Optical Preclinical Imaging Market, by End User, 2016-2028 (US$ Bn)
TABLE 40 Italy Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 41 Italy Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 42 Italy Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 43 Italy Optical Preclinical Imaging Market, by End User, 2016-2028 (US$ Bn)
TABLE 44 Spain Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 45 Spain Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 46 Spain Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 47 Spain Optical Preclinical Imaging Market, by End User, 2016-2028 (US$ Bn)
TABLE 48 Rest of Europe Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 49 Rest of Europe Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 50 Rest of Europe Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 51 Rest of Europe Optical Preclinical Imaging Market, By End-User, 2016-2028 (US$ Bn)
TABLE 52 Asia Pacific Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 53 Asia Pacific Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 54 Asia Pacific Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 55 Asia Pacific Optical Preclinical Imaging Market, by End User, 2016-2028 (US$ Bn)
TABLE 56 Asia Pacific Optical Preclinical Imaging Market, by Country, 2016-2028 (US$ Bn)
TABLE 57 China Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 58 China Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 59 China Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 60 China Optical Preclinical Imaging Market, by End User, 2016-2028 (US$ Bn)
TABLE 61 Japan Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 62 Japan Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 63 Japan Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 64 Japan Optical Preclinical Imaging Market, by End User, 2016-2028 (US$ Bn)
TABLE 65 India Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 66 India Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 67 India Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 68 India Optical Preclinical Imaging Market, by End User, 2016-2028 (US$ Bn)
TABLE 69 South Korea Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 70 South Korea Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 71 South Korea Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 72 South Korea Optical Preclinical Imaging Market, by End User, 2016-2028 (US$ Bn)
TABLE 73 South East Asia Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 74 South East Asia Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 75 South East Asia Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 76 South East Asia Optical Preclinical Imaging Market, By End-User, 2016-2028 (US$ Bn)
TABLE 77 Rest of Asia Pacific Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 78 Rest of Asia Pacific Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 79 Rest of Asia Pacific Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 80 Rest of Asia Pacific Optical Preclinical Imaging Market, By End-User, 2016-2028 (US$ Bn)
TABLE 81 Latin America Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 82 Latin America Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 83 Latin America Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 84 Latin America Optical Preclinical Imaging Market, By End-User, 2016-2028 (US$ Bn)
TABLE 85 Latin America Optical Preclinical Imaging Market, by Country, 2016-2028 (US$ Bn)
TABLE 86 Brazil Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 87 Brazil Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 88 Brazil Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 89 Brazil Optical Preclinical Imaging Market, by End User, 2016-2028 (US$ Bn)
TABLE 90 Mexico Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 91 Mexico Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 92 Mexico Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 93 Mexico Optical Preclinical Imaging Market, by End User, 2016-2028 (US$ Bn)
TABLE 94 Rest of Latin America Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 95 Rest of Latin America Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 96 Rest of Latin America Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 97 Rest of Latin America Optical Preclinical Imaging Market, By End-User, 2016-2028 (US$ Bn)
TABLE 98 Middle East and Africa Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 99 Middle East and Africa Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 100 Middle East and Africa Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 101 Middle East and Africa Optical Preclinical Imaging Market, By End-User, 2016-2028 (US$ Bn)
TABLE 102 Middle East and Africa Optical Preclinical Imaging Market, by Country, 2016-2028 (US$ Bn)
TABLE 103 GCC Countries Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 104 GCC Countries Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 105 GCC Countries Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 106 GCC Countries Optical Preclinical Imaging Market, by End User, 2016-2028 (US$ Bn)
TABLE 107 South Africa Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 108 South Africa Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 109 South Africa Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 110 South Africa Optical Preclinical Imaging Market, by End User, 2016-2028 (US$ Bn)
TABLE 111 Rest of Middle East and Africa Optical Preclinical Imaging Market, By Modality, 2016-2028 (US$ Bn)
TABLE 112 Rest of Middle East and Africa Optical Preclinical Imaging Market, By Reagent, 2016-2028 (US$ Bn)
TABLE 113 Rest of Middle East and Africa Optical Preclinical Imaging Market, By Application, 2016-2028 (US$ Bn)
TABLE 114 Rest of Middle East and Africa Optical Preclinical Imaging Market, By End-User, 2016-2028 (US$ Bn)

Frequently Asked Questions:

How does COVID-19 Impact the global optical preclinical imaging market?

The delay of non-essential medical services, the scarcity of medical facilities and treatment centers, trade restrictions, the suspension of various activities, the drop in demand, and the interruptions to the supply chain brought on by the COVID-19 outbreak all had a significant impact on healthcare.

Which is the leading market for optical preclinical imaging?

North America accounted for the highest share in the global optical preclinical imaging market.

What are the key drivers for the growth of the optical preclinical imaging market?

Increase in demand for non-invasive imaging techniques and increasing government funding for research & development activities are the major factors driving the market’s growth.

Which is the major segment in the optical preclinical imaging market by modality?

Bioluminescence/Fluorescence Imaging Systems had a major share in 2021 with the market revenue share. Besides, it is also projected to witness the fastest growth.

Which is the major segment in the optical preclinical imaging market by End-user?

The Research Institutes had a major share in the global market in 2021.

North America Cancer Diagnostics Market

Published:
Report ID: 36532

Aspergillosis Treatment Market

Published:
Report ID: 2106

Middle East And Africa Female Hygiene Products Market

Published:
Report ID: 8484

Therapeutic Monoclonal Antibodies Market

Published:
Report ID: 11175

United States Human Papillomavirus Vaccines Market

Published:
Report ID: 36384

White Canes Market

Published:
Report ID: 36378

Cancer Profiling Market

Published:
Report ID: 36289

Flowable Hemostats Market

Published:
Report ID: 36279

Fibrin Sealants Market

Published:
Report ID: 36276

Prostate Cancer Market

Published:
Report ID: 36273

ECG Telemetry Devices Market

Published:
Report ID: 36237

Blotting Systems Market

Published:
Report ID: 36233

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN